To assess whether this CI is altered in AD or modulated by the APOE ε4 allele, we quantified CI strength and APOC1 mRNA expression in PMB samples via CIS-dPCR (Table S1) and RT-qPCR. This evidence concerns the gene APOE and Alzheimer disease.